Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Carolina Liquid Chemistries Alcohol Assay Receives CLIA Moderate Complexity Rating for Abbott ImmTox 270
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
Flow Cytometry
Latest
10x Genomics Launches Next Generation of Chromium Flex to Scale Single-Cell Research
New plate-based multiplexing can profile up to 384 samples and 100 million cells per week.Â
Mass Spectrometry
Latest
New RNA-seq Kit Enables Direct Processing of 3D Spheroid Models
The extraction-free library preparation technology is designed to deliver full transcriptome coverage for drug screening and toxicology studies.
Immunoassay
Latest
DPYD Genotyping Assay Receives FDA Breakthrough Device Designation
The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.
Molecular Diagnostics
Latest
Countable Labs Adds RNA Module to PCR Platform for Direct RNA Quantification
The new module enables one-step reverse transcription and amplification, removing cDNA prep and supporting applications in translational research, cell and gene therapy manufacturing, and diagnostic development.
Point-of-Care
Latest
Monod Bio Taps AI Protein Design to Build Rapid Point-of-Care Preeclampsia Test
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.